Baird Financial Group
CLB icon

Baird Financial Group’s Core Laboratories CLB Stock Holding History

Baird Financial Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,714
Closed -$232K – 1721
2022
Q2 		$232K Sell
11,714
-21,778
-65% -$579K ﹤0.01% 1651
2022
Q1 		$1.06M Buy
33,492
+3,657
+12% +$103K ﹤0.01% 1125
2021
Q4 		$666K Sell
29,835
-10,967
-27% -$286K ﹤0.01% 1355
2021
Q3 		$1.13M Buy
40,802
+5,523
+16% +$168K ﹤0.01% 1155
2021
Q2 		$1.37M Buy
35,279
+2,781
+9% +$99.7K ﹤0.01% 1054
2021
Q1 		$936K Buy
32,498
+11,335
+54% +$387K ﹤0.01% 1156
2020
Q4 		$561K Sell
21,163
-1,733
-8% -$35.4K ﹤0.01% 1198
2020
Q3 		$349K Sell
22,896
-15
-0.1% -$315 ﹤0.01% 1258
2020
Q2 		$466K Sell
22,911
-348
-1% -$6.24K ﹤0.01% 1158
2020
Q1 		$240K Sell
23,259
-223,125
-91% -$6.24M ﹤0.01% 1278
2019
Q4 		$9.28M Sell
246,384
-184,826
-43% -$8.3M 0.03% 386
2019
Q3 		$1.78M Sell
431,210
-268
-0.1% -$12.5K 0.01% 808
2019
Q2 		$22.6M Buy
431,478
+25,628
+6% +$1.5M 0.09% 241
2019
Q1 		$28M Buy
405,850
+75,258
+23% +$5.05M 0.16% 167
2018
Q4 		$19.7M Sell
330,592
-4,286
-1% -$370K 0.13% 197
2018
Q3 		$38.8M Buy
334,878
+47,834
+17% +$5.4M 0.24% 124
2018
Q2 		$36.2M Buy
287,044
+7,054
+3% +$859K 0.25% 121
2018
Q1 		$30.3M Buy
279,990
+5,562
+2% +$616K 0.21% 140
2017
Q4 		$30.1M Buy
274,428
+58,577
+27% +$5.85M 0.21% 139
2017
Q3 		$21.3M Sell
215,851
-7,195
-3% -$697K 0.16% 165
2017
Q2 		$22.6M Buy
223,046
+10,795
+5% +$1.16M 0.18% 156
2017
Q1 		$24.5M Sell
212,251
-10,142
-5% -$1.18M 0.2% 148
2016
Q4 		$26.7M Buy
222,393
+76,621
+53% +$8.48M 0.23% 132
2016
Q3 		$16.4M Buy
145,772
+10,099
+7% +$1.16M 0.15% 168
2016
Q2 		$16.8M Sell
135,673
-132,583
-49% -$16M 0.15% 169
2016
Q1 		$30.2M Buy
268,256
+217,682
+430% +$22.6M 0.29% 102
2015
Q4 		$5.5M Sell
50,574
-184
-0.4% -$21.1K 0.06% 321
2015
Q3 		$5.07M Buy
50,758
+7,209
+17% +$784K 0.05% 326
2015
Q2 		$4.97M Buy
+43,549
New +$5.28M 0.05% 340

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Baird Financial Group's CLB Position: Q3 2022 in Review

Baird Financial Group sold out of Core Laboratories (CLB) in Q3 2022, closing a stake of 11,714 shares — an estimated $232K sold.

Baird Financial Group first reported a position in CLB in Q2 2015 and held it in 29 quarters. The position peaked at $38.8M in Q3 2018. 162 funds tracked by Wall St. Rank hold CLB as of Q3 2022.

  • Baird Financial Group reported no remaining Core Laboratories position as of Q3 2022 after selling out during the quarter.
  • Baird Financial Group sold 11,714 Core Laboratories shares in Q3 2022, an estimated $232K.
  • Baird Financial Group first reported a position in Core Laboratories in Q2 2015 and held it in 29 quarters.
  • Baird Financial Group's Core Laboratories position peaked at $38.8M in Q3 2018.
  • 162 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2022.

Based on Baird Financial Group's 13F filing for Q3 2022, filed 15 Nov 2022.